EddingPharm Secures China NMPA Approval for Vascepa

Amarin Corporation plc, an innovative pharmaceutical firm, stated that its commercial partner in Mainland China (China), EddingPharm (Edding), has gained regulatory approval for Vascepa (icosapent ethyl) from the National Medical Products...

Abbott Drives Vertigo Understanding With 'Chakkar Ko Check Kar' campaign

Abbott, the global healthcare leader, launched its ‘Chakkar Ko Check Kar’ campaign in India to highlightanoften-overlooked balance disorder,vertigo, which affects close to 70 million people in India.Vertigo is a condition that can make people feel...

Antidote and Seqster Join Hands To Advance Patient Identification

Antidote Technologies, a digital health firm that focuses on patient engagement to advance recruitment for clinical trials, and SEQSTER PDM Inc., the leading patient-centric healthcare technology company, declared an agreement to improve patient...

Unlock The Future Of Beauty At Cosmetics Ingredients Expo: Innovation, Sustainability & Industry Expertise On Display

Get ready for the highly anticipated Cosmetics Ingredients Expo 2024, a premier event that will bring together the best minds and leading innovators in the cosmetics industry.

Ligand Pharma To Acquire APEIRON Biologics For USD 100 Million

Ligand Pharmaceuticals, a biopharmaceutical company, delcared that it has forayed into a definitive contract to acquire APEIRON Biologics AG, which holds royalty rights to QARZIBA® (dinutuximab beta) for the treatment of high-risk neuroblastoma...

US FDA Nods Biostar Pharma's IND application For Phase 2 Study

Biostar Pharma, Inc., the US subsidiary of Beijing Biostar Pharmaceuticals Co., Ltd. (Biostar), a synthetic biology-driven biopharma firm focused on the creation and marketing of innovative oncology drugs, declared that the US FDA had approved...

© 2024 India Pharma Outlook. All Rights Reserved.